Dr. Theo Schetters - Analysis of Covid Vaccine Safety in the Netherlands

Jul 10, 2023
Source: www.rumble.com/v2xuy96-analysis-of-covid-vaccine-safety-in-the-netherlands-dr-theo-schetters.html?mref=6zof&mrefc=5

25 October 2022 | Following his analysis of data on all cause and excess mortality in the Netherlands, Prof Theo Schetters gave a presentation in Amsterdam in August 2022 showing a temporal association between the Covid-19 vaccinations and excess mortality.

It was because of Theo’s extensive background in, and knowledge of vaccine development, that he voiced concerns over the lack of data regarding the safety and efficacy of the vaccines, stating “mass mRNA vaccination is reckless and unnecessary”.

Prof Schetters has a BSc in biology, an MSc in immunology and parasitology and a PhD in medicine and has worked in vaccine research for more than forty years wth several patents to his name. For 26 of those years Theo worked at Intervet International, a large animal health company. Whilst there he developed vaccines against Coccidiosis in chickens and Babesia in dogs. In collaboration with the University of Montpellier, Theo invented recombinant vaccines against Babesia canis and Babesia divergens. He has also developed an improved vaccine formulation against Rhipicephalus ticks.

In 2017 Theo was appointed Extraordinary Professor at the University of Pretoria. His work there involved researching and developing recombinant vaccines for the treatment of ticks and tick-borne diseases. Theo is also the director of ProtActivity, a company which focuses on the development of vaccines against protozoal diseases in animals.